Guide for Authors
Vascular Pharmacology publishes papers, written in English, which contain results of all aspects of biology and pharmacology of the vascular system.
Papers are encouraged in all areas, including angiogenesis, growth factors, nitric oxide, cell signaling, vasoactive mediators, hypertension, atherosclerosis, metabolic diseases, blood element-vessel wall interactions, thrombosis, micro-circulation, vascular developmental biology and remodeling, vascular inflammation and immunity. Papers are encouraged on pharmacological research utilizing approaches ranging from molecular biology to integrative physiology.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all Authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher.
It is essential to give a fax number and e-mail address when submitting a manuscript.
For more details on how to write a world class paper, please visit our Pharmacology Author Resources page.
Authors are encouraged to submit video material or animation sequences to support and enhance your scientific research. For more information please see the paragraph on video data below.
Fast processing option
If your article has previously been rejected from another journal, the Editors can process your submission to Vascular Pharmacology more quickly if the previously received reviewer's comments are made available to them. Please note that these will have to be sent (by email) by the Editor(s) of the respective other journal, we do not accept reviewer's comments submitted from the authors themselves. For questions please contact vph@elsevier.com .
Types of paper
Research articles
Original research articles present data that advances the science and clinical practice of vascular pharmacology. These manuscripts should present well-rounded studies reporting innovative advances that further knowledge about a topic of importance to the specialty of vascular pharmacology. Each manuscript should contain an abstract with clearly state an objective or hypothesis; the design and methods; the main outcome measures; the main results of the study; a discussion section placing the results in context with the published literature as well as study limitations; and the conclusions and relevant implications for clinical practice or health policy along with references and figure legends.
The text of research article should be limited to 5000 words including title, abstract, tables, figures, and references list with not more than 5 figures and tables and 40 references.
Please upload your manuscript via Editorial Manager choosing manuscript type “research article”.
Reviews
These should provide a balanced synthesis of current knowledge and constructive suggestions on vascular pharmacology related themes. They should cover aspects of a topic in which scientific consensus exists as well as aspects that remain controversial and are the subject of ongoing scientific research. All articles and data sources reviewed should include information about the specific type of study or analysis, population, intervention, exposure, and tests or outcomes. All articles or data sources should be selected systematically for inclusion in the review and critically evaluated.
Reviews shall have a maximum length of 6,000 words (the word count limit includes title, abstract, tables, figures, and references list). They should have an abstract of not more than 200 words, not more than 80 references and up to 8 figures/tables.
Please upload your manuscript via Editorial Manager choosing manuscript type “Review”.
……
更多详情：
https://www.elsevier.com/journals/vascular-pharmacology/1537-1891/guide-for-authors
